Title
Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex
Document Type
Article
Date of Publication
2017
Publication Title
Cancer Discovery
First Page
302
Last Page
321
DOI
https://doi.org/10.1158/2159-8290.cd-16-0653
Recommended Citation
Zawistowski, J.; Miller, M.; Goulet, D.; Stuhlmiller, T.; Beltran, A.; Olivares-Quintero, J.; Singh, D.; Sciaky, N.; Parker, J.; Rashid, N.; Chen, X.; Duncan, J.; Whittle, M.; Angus, S.; Verlarde, S.; Golitz, B.; He, X.; Santos, C.; Darr, D.; Gallagher, K.; Graves, L.; Perou, C.; Carey, L.; Earp, H. S.; and Johnson, G., "Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacological targeting of the p-TEFb complex" (2017). Pharmaceutical Sciences. 2326.
https://cufind.campbell.edu/pharmacy/2326
